We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Heart Rate Variability in White Coat Hypertension and Essential Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00286884
Recruitment Status : Completed
First Posted : February 6, 2006
Last Update Posted : September 11, 2006
Information provided by:
Regional Hospital Holstebro

Brief Summary:
The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.

Condition or disease Intervention/treatment
Essential Hypertension White Coat Hypertension Healthy Procedure: Monitoring of heart rate variability

Study Type : Observational
Estimated Enrollment : 65 participants
Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Prospective

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   30 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • age 30-70 years
  • office BP >150/95 mmHg and 24-h ambulatory BP =/>135/85 mmHg
  • office BP >150/95 mmHg and 24-h ambulatory BP <135/85 mmHg
  • office BP <150/95 mmHg and 24-h ambulatory BP <135/85 mmHg

Exclusion Criteria:

  • Clinical signs of disease of the heart, lungs, liver, kidneys, brain or endocrine organs
  • neoplastic disease
  • daily use of medicine
  • alcohol abuse
  • abnormal laboratory screening including blood-hemoglobin, blood-white cell count, plasma-creatinine, plasma-alanine-amino-transaminases, plasma-albumin, plasma-sodium, plasma-potassium, urinary glucose, urinary albumin; electrocardiogram
  • pregnancy
  • unwillingness to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00286884

Department of Medical Research, Holstebro Hospital
Holstebro, Denmark, 7500
Sponsors and Collaborators
Regional Hospital Holstebro
Principal Investigator: Line B Madsen, MD Regional Hospital Holstebro
Study Chair: Erling B Pedersen, MD Regional Hospital Holstebro

ClinicalTrials.gov Identifier: NCT00286884     History of Changes
Other Study ID Numbers: MED.RES.HOS.2003.01.LBM
First Posted: February 6, 2006    Key Record Dates
Last Update Posted: September 11, 2006
Last Verified: September 2006

Additional relevant MeSH terms:
White Coat Hypertension
Vascular Diseases
Cardiovascular Diseases